Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multi-center, Randomized, Double-blind, Vehicle-controlled, Phase-2 Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients

Trial Profile

A Multi-center, Randomized, Double-blind, Vehicle-controlled, Phase-2 Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 26 Jun 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs VBP 926 (Primary)
  • Indications Paronychia
  • Focus Therapeutic Use
  • Sponsors Veloce BioPharma
  • Most Recent Events

    • 26 Jun 2019 Results assessing efficacy and safety of a topical povidone-iodine formulation in patients with paronychia published in the Investigational New Drugs
    • 09 Oct 2018 Status changed from active, no longer recruiting to completed.
    • 03 Oct 2018 According to a Veloce BioPharma media release, Mario Lacouture, MD, Director, Oncodermatology Program at Memorial Sloan Kettering Cancer Center is one of the lead investigators of the study.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top